Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ALVO Alvotech > Detailed Quotes

ALVO Alvotech

Watchlist
12.850
+0.070+0.55%
Close  02/07 16:00 ET
12.8500.0000.00%
Post Mkt Price 02/07 16:00 ET
High
12.950
Open
12.840
Turnover
1.74M
Low
12.800
Pre Close
12.780
Volume
134.95K
Market Cap
3.20B
P/E(TTM)
Loss
52wk High
14.040
Shares
248.65M
P/E(Static)
Loss
52wk Low
5.200
Float Cap
918.93M
Bid/Ask %
-42.86%
Historical High
14.040
Shs Float
71.51M
Volume Ratio
2.66
Historical Low
5.200
Dividend TTM
--
Div Yield TTM
--
P/B
-11.52
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.19%
Amplitude
1.17%
Avg Price
12.878
Lot Size
1
Float Cap
918.93M
Bid/Ask %
-42.86%
Historical High
14.040
Shs Float
71.51M
Volume Ratio
2.66
Historical Low
5.200
Dividend TTM
--
P/B
-11.52
Dividend LFY
--
Turnover Ratio
0.19%
Amplitude
1.17%
Avg Price
12.878
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Alvotech (formerly Oaktree Acquisition Corp. II) is a biotech company, founded by Robert Wessman.Alvotech are 800 professionals across multiple countries,focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Alvotech’s current pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer.
CEO: Mr. Mark Levick
Market: NASDAQ
Listing Date: 09/17/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist